Brought to you by 
Baxter to market Nycomed's TachoSil in the US
15 Jan 2008
Executive Summary
Nycomed has chosen Baxter International to market its TachoSil hemostasis patch exclusively in the US.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
-
Surgical Equipment & Devices
- Surgical Sealants
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Baxter to market Nycomed's TachoSil in the US
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice